Liver fibrosis has evolved in the past 20 years from a pure laboratory discipline to an area of
great bedside relevance to practicing hepatologists. This evolution reflects growing awarenessnotonlyofthemolecularunderpinn …

Abreviaturas usadas en este Trabajo: IC: intervalo de confianza; RVT: respuesta virológica
temprana; TAAA: terapia antirretroviral altamente activa; IHA: índice histiológico activo; VIH …

Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …

Background & Aims: The purpose of our study was to prospectively compare the success
rate and diagnostic accuracy of magnetic resonance elastography, ultrasound elastography …

Characteristics for an optimal liver biopsy specimen were recently defined as 20 to 25 mm
long and/or containing more than 11 complete portal tracts (CPTs). A systematic review of …

Background: The natural history of hepatitis C virus (HCV) infection remains uncertain.
Previous data concerning rates of progression are from studies using estimated dates of …

Studies of the prognostic value of Ishak fibrosis stage are lacking. We used multi‐year follow‐
up of the Hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial to …

Background & Aims: A convincing, yet inconsistent, pattern has emerged that demonstrates
increased progression of HCV-related liver disease with heavy alcohol use. The aim was to …

Chemokines, chemotactic cytokines, may promote hepatic inflammation in chronic hepatitis
C virus (HCV) infection through the recruitment of lymphocytes to the liver parenchyma. We …

Background/Aims: Steatosis is common in patients with hepatitis C virus (HCV) infection. Its
influence on disease progression is only partially understood. The aim of this study was to …